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Abstract. 
 
MIHA is an inhibitor of apoptosis protein
(IAP) that can inhibit cell death by direct interaction
with caspases, the effector proteases of apoptosis. DI-
ABLO is a mammalian protein that can bind to IAPs
and antagonize their antiapoptotic effect, a function
 
analogous to that of the proapoptotic 
 
Drosophila
 
 mole-
cules, Grim, Reaper, and HID. Here, we show that after
UV radiation, MIHA prevented apoptosis by inhibiting
caspase 9 and caspase 3 activation. Unlike Bcl-2,
MIHA functioned after release of cytochrome
 
 c 
 
and
DIABLO from the mitochondria and was able to bind
to both processed caspase 9 and processed caspase 3 to
prevent feedback activation of their zymogen forms.
Once released into the cytosol, DIABLO bound to
MIHA and disrupted its association with processed
caspase 9, thereby allowing caspase 9 to activate cas-
pase 3, resulting in apoptosis.
Key words: apoptosis • IAPs • DIABLO • caspases •
BIR
 
Introduction
 
Inhibitors of apoptosis (IAPs)
 
1
 
 were first identified as bac-
uloviral genes that could suppress apoptosis of infected in-
sect cells (Crook et al., 1993). Cellular IAP homologues
such as MIHA (the human homologue is known as XIAP
and hILP) (Duckett et al., 1996; Liston et al., 1996; Uren et
al., 1996) have been identified that can directly bind to ac-
tivated caspases (Kaiser et al., 1998; Hawkins et al., 1999;
Meier et al., 2000) and inhibit apoptosis in response to a
diverse range of stimuli (LaCasse et al., 1998; Uren et al.,
1998). While not all IAPs have been shown to bind to
caspases, all bear one or more copies of a motif termed a
baculoviral IAP repeat (BIR) (Crook et al., 1993; Clem
and Miller, 1994). These motifs are required for the inter-
action with caspases.
XIAP, which bears three BIRs, can bind to and inhibit
 
active, processed caspase 3 with a 
 
K
 
i
 
 of 0.7 nM (Deveraux
et al., 1997; Roy et al., 1997; Takahashi et al., 1998). Its sec-
ond BIR (BIR2) and flanking regions NH
 
2
 
 terminal to it
have been shown to be necessary and sufficient for caspase
3 inhibition in vitro (Takahashi et al., 1998). XIAP has
also been reported to bind to caspase 9 in both its zy-
mogen and processed form (Sun et al., 2000), as well as to
inhibit caspase 9 activity in vitro (Deveraux et al., 1998).
However, in this case the interaction involves the COOH-
terminal half of XIAP which contains BIR3 and a RING
finger domain (Deveraux et al., 1999).
In both insects and mammals, proapoptotic proteins that
bind directly to IAPs can antagonize IAP activity. For ex-
ample, in 
 
Drosophila
 
, DIAP1 is directly bound and antag-
onized by Grim, HID, and Reaper (Hay et al., 1995; Vucic
et al., 1997, 1998; Song et al., 2000), and Grim, HID, and
Reaper killing probably requires this interaction with IAPs
(Wang et al., 1999; Goyal et al., 2000). These 
 
Drosophila
 
proapoptotic molecules can also induce apoptosis of mam-
malian cells and bind to mammalian IAPs (Claveria et al.,
1998; McCarthy and Dixit, 1998; Haining et al., 1999). The
only mammalian protein known to bind to and antagonize
the antiapoptotic effects of IAPs is DIABLO (also known
as Smac) (Du et al., 2000; Verhagen et al., 2000).
To determine how DIABLO acts to promote apoptosis
and how MIHA functions to inhibit it, we analyzed their
interactions with each other and with caspases in NT2 cells
exposed to apoptotic stimuli and in a yeast system in which
the Apaf-1, caspase 9, and caspase 3 pathway had been re-
constituted. To inhibit apoptosis, MIHA functioned down-
stream of mitochondrial release of cytochrome
 
 c
 
 and DI-
ABLO. MIHA was able to inhibit caspase 9 and caspase 3
processing after UV radiation of NT2 cells and was able to
bind to both processed caspase 3 and processed caspase 9,
indicating it functioned mainly at the level of processed
caspase 9. The pattern of caspase activation in mammalian
cells and in yeast revealed that caspase 3 and caspase 9 are
involved in a feedback amplification loop that can be in-
hibited by MIHA. When expressed at sufficient levels, DI-
ABLO was able to promote caspase activation by disrupt-
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ing the interaction between MIHA and processed caspase
9, thereby leading to apoptosis.
 
Materials and Methods
 
Cell Culture and Transfection
 
293T cells and NT2 cells (a kind gift from D. Nicholson, Merke-Frosst,
Quebec, Canada) were maintained in DME supplemented with 10% FCS.
Cells were transfected using Effectene (QIAGEN) following the manufac-
turer’s protocol. For experiments in 6-well plates (Nunc), cells were
seeded at a density of 10
 
5
 
 cells per well 24 h before transfection. A total of
0.2 
 
m
 
g DNA was used for transfections in 6-well plates along with 2.5 
 
m
 
l of
transfection reagent. For experiments in 100-mm plates, 2–3 
 
3 
 
10
 
6
 
 cells per
plate were seeded 24 h before transfection, and a total of 1–2 
 
m
 
g of DNA
was used along with 10 
 
m
 
l (293T cells) or 12 
 
m
 
l (NT2 cells) of Effectene.
Stable cell lines were made by transfecting NT2 cells with 2 
 
m
 
g of DNA
linearized by digestion with Fsp1 (New England Biolabs, Inc.). 2 d after
transfection, cells were split into four separate plates and puromycin (8
 
m
 
g/ml) added to the media. Several clones from each individual plate were
selected and tested for expression of protein by flow cytometry and by
Western blot.
 
Mammalian Cell Constructs
 
NH
 
2
 
-terminally Flag-tagged MIHA was cloned into the pEF vector (Uren
et al., 1996; Huang et al., 1997). Bcl-2, LacZ, and caspase 9 were also
cloned into the pEF vector but were not Flag-tagged. Untagged DIABLO
was expressed in the pEF vector as described previously (Verhagen et al.,
2000). Caspase 9 was cloned by PCR from an HeLa cDNA library us-
ing the following primers: 5
 
9
 
-CGGGGATCCCCATGGACGAAGCG-
GATCGGCGGC -3
 
9
 
 and 5
 
9
 
-GCTCTAGATTAGCTAGCTGATGTTT-
TAAAGAAAAGTTTTTTCC-3
 
9
 
. The PCR product was digested with
BamH1 and Xba1 and subcloned into the pEF vector. The caspase re-
cruitment domain (CARD) of caspase 9 was PCR amplified with primers
5
 
9
 
- CG GGA TCC ACC ATG TCC GGT GCT CTT GAG AGT TTG
A-3
 
9 
 
and 5
 
9
 
-GC TCTAGA TTA GCTAGC TGA TGT TTT AAA GAA
AAG TTT TTTCC-3
 
9
 
, cut with BamHI and XbaI, and subcloned into the
pEF vector.
 
Yeast Constructs
 
Yeast vectors driving expression from either the constitutive ADH pro-
moter or the inducible Gal1/10 promoter based on the pRS31X series of
yeast vectors (Sikorski and Hieter, 1989) have been described previously
(Hawkins et al., 1999, 2000; Wang et al., 1999). pGALL-(URA), was gen-
erated by swapping the PvuI fragment of pGALL-(TRP1) (Hawkins et al.,
1999) containing the TRP-1 gene with that of pRS316 containing the
URA selection gene. Various coding sequences were inserted into these
vectors as detailed below. Plasmids expressing Apaf-1
 
1–530
 
, caspase 9, and
p35 have been described previously (Hawkins et al., 1999; Wang et al.,
1999). The coding region of MIHA was excised from pGALL-(
 
HIS3
 
)-
MIHA (Hawkins et al., 1999) and ligated into pADH-(
 
TRP1
 
). Caspase 3
was amplified from CPP32 (Fernandes et al., 1994) with oligonucleotides 1
and 2. The resulting product was digested with BamHI and XbaI and
cloned into pGALL-(
 
URA
 
).
The sequences of the oligonucleotides used in these PCR reactions
were: 1, CGGGATCCATGGAGAACACTGAAAACTCAGTGG; and
2, GCTCTAGATTAGTGATAAAAATAGAGTTCTTTTGTGAGC.
 
Yeast Transformation, Growth, and Immunoblotting
 
The yeast strain W303-
 
a
 
 was used. Immunoblotting was performed as de-
scribed previously (Hawkins et al., 1999; Hawkins et al., 2000) using a rabbit
anti-caspase 3 antibody (BD PharMingen) at 1:2,000 and a mouse anti-
caspase 9 antibody (Oncogene Research Products) at 1:200. The HRP-
conjugated secondary antibodies were anti–rabbit IgG (H
 
1
 
L) (Pierce
Chemical Co.) and anti–mouse IgG (Fab) (Sigma-Aldrich) used at 1:200,000
and 1:10,000, respectively. For enhanced chemiluminescence detection,
Supersignal West Pico Substrate (Pierce Chemical Co.) was used.
 
Death Assays
 
Cells were washed twice in PBS in the tissue culture plate, and after re-
moval of the PBS and the lid of the tissue culture plate, the cells were ex-
 
posed to UV radiation in a tissue culture hood. The intensity of the UV ra-
diation was measured using a Spectroline DM-254N ultraviolet light meter.
The time required to give a certain dose (J/m
 
2
 
) of UV radiation is given by
the formula: time 
 
5 
 
desired dose/(
 
m
 
W/cm2
 
 3 
 
1
 
e
 
 2 
 
2
 
). The times for the
doses used were: 10 J/m
 
2
 
 
 
5 
 
11 s, 25 J/m
 
2
 
 
 
5 
 
26 s, 50 J/m
 
2
 
 
 
5 
 
55 s, and 100 J/m
 
2
 
 
 
5
 
111 s. 6 h after UV radiation, the cells were treated with trypsin, removed
from the plate, washed in DME supplemented with 10 mM CaCl
 
2
 
, and in-
cubated with FITC coupled or biotinylated annexin V (a kind gift from D.
Huang and A. Strasser, The Walter and Eliza Hall Institute) at a dilution of
1:100 in 100 
 
m
 
l of DME with CaCl
 
2
 
 and 5% FCS, for 20 min at room tem-
perature. Cells were then washed twice and incubated with Streptavidin
coupled to either Tricolor (when cells were also transfected with GFP) or
phycoerythrin (Caltag) in a dilution of 1:50 in DME with CaCl
 
2
 
 and 5%
FCS for 10 min on ice. Cells were analyzed by flow cytometry.
For serum withdrawal, NT2 cells were washed three times in serum-
free DME and then placed in serum-free DME. At various time points af-
ter serum withdrawal, the supernatant (which contained dead, nonadher-
ent cells) and the remainder of the cells were removed from the plate with
trypsin, washed, and incubated with 2 
 
m
 
g/ml propidium iodide (PI) and
analyzed by flow cytometry for PI uptake.
 
Flow Cytometry
 
Analysis was done using a FACScan™ (Becton Dickinson). PI was as-
sessed using the FL-3 channel. To determine annexin V staining of tran-
siently transfected cells, the successfully transfected cells (GFP-positive
and fluorescent in the FL-1 channel) were gated and the percentage of an-
nexin Tricolor–positive cells was determined in the FL-3 channel. To
determine the annexin staining of nontransfected cells, the Streptavidin-
phycoerythin secondary agent was used and the percentage of annexin-
positive cells was determined in the FL-2 channel.
 
Western Blots and Immunoprecipitation
 
Lysates were made from 
 
z
 
5 
 
3 
 
10
 
6
 
 293T cells or NT2 cells cultured in 100-
mm plates. All cells, including nonadherent cells in the supernatant, were
washed twice in cold PBS and then lysed by gentle rotation in 500 
 
m
 
l of ly-
sis buffer (150 mM NaCl, 10% glycerol, 1% Triton X-100, 2 mM EDTA, 1
mM PMSF, 40 mg/ml aprotinin, 20 mg/ml leupeptin) for 1 h at 4
 
8
 
C. The ly-
sates were then spun at 10,000 rpm for 10 min and the supernatant was re-
tained. These lysates were then used in Western blots or for immunopre-
cipitation. For Western blotting, 20–30 
 
m
 
l of lysate was run on a 4–20%
gradient polyacrylamide gel (Gradipore) and then transferred to nitrocel-
lulose membrane (Hybond-C; Amersham Pharmacia Biotech). After
transfer, the membranes were washed in PBS and then blocked in 5%
milk in PBS for 1 h and immunoblotted with primary antibody also in 5%
milk. The antibodies used are listed below. As a control, agarose-coupled
mouse IgG was also used to ensure protein pulled down did not nonspecif-
ically associate with the beads (data not shown).
Anti-Flag immunoprecipitations were done by mixing 30 
 
m
 
l of agarose-
coupled anti-Flag M2 (Sigma-Aldrich) resuspended in lysis buffer with
200 
 
m
 
l of lysate and the total volume was then made up to 1 ml using lysis
buffer. This was gently rotated at 4
 
8
 
C for 1 h. The beads were pelleted by
brief centrifugation and washed three times in lysis buffer. Immunoprecip-
itated protein was eluted by resuspending the beads in 120 
 
m
 
l (i.e., four
times the volume of beads used) of 100 mM glycine, pH 3.0, spinning
down the beads, and retaining the supernatant which was neutralized by
the addition of 1:10 vol (12 
 
m
 
l) of Tris-HCl, pH 8.0. The immunoprecipi-
tate was then boiled for 5 min in loading buffer and run on 4–20% gradi-
ent polyacrylamide gel (Gradipore), transferred to nitrocellulose mem-
brane (Hybond-C; Amersham Pharmacia Biotech), and immunoblotted
with the appropriate antibody.
The primary antibodies used were: anti-Flag M2 (Sigma-Aldrich), anti-
caspase 3 (rabbit polyclonal; PharMingen), anti-caspase 9 (rabbit poly-
clonal; BD PharMingen) (designated A in Figs. 1–5), anti-caspase 9 (rabbit
polyclonal; New England Biolabs, Inc.) (designated B in Figs. 1–5), anti-
Smac (rabbit polyclonal; a kind gift from X. Wang, The Howard Hughes
Medical Institute, University of Texas, Dallas, TX), anti-CARD caspase 9
(mouse monoclonal; a kind gift from Y. Lazebnik, Cold Spring Harbor
Laboratory, Cold Spring Harbor, NY), anti-cytochrome
 
 c
 
 (mouse mono-
clonal; BD PharMingen), and anti-XIAP (mouse monoclonal; MBL [Aba-
cus]). The secondary antibodies used were: goat anti–rabbit-HRP (South-
ern Biotechnology Associates, Inc.) and goat anti–mouse-HRP (Southern
Biotechnology Associates, Inc.). ECL Western blotting reagents (Amer-
sham Pharmacia Biotech) were used to detect antibody signal. All autora-
diographs were scanned into Adobe Photoshop®, and the figures were
made using Adobe Freehand v9. 
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Digitonin Fractionation of NT2 Cells
 
Digitonin fractionation of cells into cytosolic and membrane fractions was
performed as described previously (Ramsby et al., 1994). In brief, NT2
cells were plated at 1.5 
 
3 
 
10
 
6
 
 cells/10-cm plate and were UV irradiated (50
J/m
 
2
 
) 0, 3, or 6 h before harvest. The cells were scraped off the plate and
washed one time with cold PBS. The cells were then suspended in 200 
 
m
 
l
of 0.025% digitonin (Calbiochem) in a lysis buffer (250 mM sucrose, 20
mM Hepes, pH 7.4, 5 mM MgCl
 
2
 
, 10 mM KCl, 1 mM EDTA, 1 mM
EGTA, 1 mM PMSF, 10 
 
m
 
g/ml aprotinin, and 10 
 
m
 
g/ml leupeptin). After
10 min, the cells were centrifuged (2 min, 13,000 rpm) and the supernatant
was removed (cytosolic fraction). The remaining pellet was resuspended in
200 
 
m
 
l RIPA lysis buffer (150 mM NaCl, 1.0% NP-40, 0.5% deoxycholate,
0.1% SDS, 50 mM Tris-HCl, pH 8.0), lysis was allowed to proceed for a
further 30 min, and cellular debris was removed by centrifugation. The su-
pernatant comprising the membrane fraction was retained.
 
Results
 
MIHA Inhibits UV Radiation–induced Apoptosis, 
Caspase 3 and Caspase 9 Processing, but Not Serum 
Withdrawal–induced Apoptosis
 
NT2 cells stably expressing MIHA or Bcl-2 are protected
from UV-induced apoptosis (Verhagen et al., 2000). How-
ever, only lines expressing Bcl-2 were able to inhibit death
induced by serum starvation (data not shown). These re-
sults indicated that levels of MIHA that were sufficient to
protect against apoptosis induced by UV radiation were
inadequate to inhibit apoptosis induced by serum with-
drawal.
To determine whether MIHA acted upstream or down-
stream of caspase activation, lysates from UV-treated and
serum-starved cells were probed with antibodies against
caspase 3 and caspase 9 (Fig. 1, A–C). In control (LacZ-
transfected) cells in response to UV radiation, most
caspase 9 and some caspase 3 was processed by 6 h (Fig. 1
A, lanes 2, 4, 6, and 8). In contrast, in cells expressing
MIHA, cleavage of caspase 9 and caspase 3 was greatly re-
duced (Fig. 1 A, lanes 1, 3, 5, and 7). By 24 h after UV
treatment (Fig. 1 C), cleavage of caspase 9 but not caspase
3 was observed in MIHA-expressing cells (Fig. 1 C, lanes 5
and 6), whereas cells expressing Bcl-2, which were used as
a positive control for protection against UV radiation–
induced apoptosis, showed minimal processing of caspase
9 and caspase 3 (Fig. 1 C, lanes 3 and 4). Control cell lines
showed almost complete cleavage of caspase 9 and partial
cleavage of caspase 3 (Fig. 1 C, lanes 1 and 2). These re-
sults suggest that both Bcl-2 and MIHA inhibit UV-
induced apoptosis at a point before caspase 9 and caspase
 
Figure 1.
 
(A) MIHA and Bcl-2 inhibit caspase 9 and caspase 3
processing in response to UV radiation but not serum with-
drawal, and MIHA binds to endogenous, processed caspase 3.
NT 2 cells stably transfected with MIHA (M) or LacZ (C) were
exposed to 100 J/m
 
2
 
 UV radiation and lysates were harvested at
6 h. Kinetics of caspase processing was followed using Western blot
immunoblotted with anti-caspase 3 and anti-caspase 9 antibodies.
Full-length caspase 9 and the cleaved 37-kD fragment of caspase
9, full-length caspase 3, and the 20- and 17-kD large subunits are
indicated. Almost complete processing of caspase 9 was observed
in control cells, and this was inhibited by the stable expression of
MIHA. Caspase 3 processing was also inhibited by MIHA, since
most caspase 3 in the MIHA line remained in the unprocessed
form (lane 7) compared with control cells (lane 8). (B) NT2 cells
stably transfected with MIHA (M) or LacZ (C) were grown un-
der serum-free conditions and lysates were harvested and immu-
noblotted with anti-caspase 3 and anti-caspase 9 antibodies.
Caspase 3 cleavage occurred in both MIHA- and LacZ-express-
ing cells. Over the time course, most caspase 9 remained in the
full-length rather than cleaved form. (C) NT2 cells stably ex-
pressing MIHA, LacZ, or Bcl-2 were exposed to 100 J/m
 
2
 
 UV ra-
diation and the lysates were harvested 24 h later and immuno-
blotted with anti-caspase 9 and anti-caspase 3 antibodies. MIHA
lines inhibited caspase 9 and caspase 3 cleavage but not to the
same degree as Bcl-2. In all the Western blots, anti-HSP70 immu-
noblotting was done as loading controls. (D) Flag-tagged MIHA
was immunoprecipitated from the lysates of NT2 cells stably ex-
pressing MIHA or LacZ that were cultured in serum-containing
media (C), or exposed to 100 J/m
 
2
 
 (UV), or were cultured in se-
rum-free media for 24 h (
 
2
 
S), and the immunoprecipitate was
probed with anti-caspase 3 and anti-caspase 9 antibodies. Pro-
cessed endogenous caspase 3 coimmunoprecipitated with MIHA
after serum withdrawal and UV radiation. No association with
caspase 9 in either its zymogen or processed form was detected. 
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3 are fully processed, although MIHA incompletely inhib-
its caspase 9 processing.
Analysis of caspase activation in the serum-starved cells
(Fig. 1, B and C) revealed that little caspase 9 processing
occurred in any of the lines, with most remaining as the 50-
kD proform. Caspase 3 cleavage did occur and was not in-
hibited by MIHA (Fig. 1 C, lanes 3–8). These experiments
suggest that caspase 9 does not play a significant role in se-
rum withdrawal–induced apoptosis. Because MIHA could
prevent caspase 3 activation after UV irradiation, but not
after serum starvation, these results also imply that cas-
pase 3 activation occurs by different pathways after each
apoptotic stimulus.
 
MIHA Binds to Endogenous, Processed Caspase 3 but 
Not Procaspase 9
 
To determine whether MIHA acts on caspases directly, we
performed coimmunoprecipitations from lysates obtained
from the same NT2 lines used to demonstrate caspase
cleavage in response to UV radiation and serum with-
drawal (Fig. 1 D). Although both the zymogen and pro-
cessed forms of caspase 3 were present in the lysates,
MIHA only coimmunoprecipitated the processed form of
caspase 3 (Fig. 1 D, lanes 3 and 4). MIHA did not coimmu-
noprecipitate any procaspase 9. These data suggest that
MIHA is able to bind to processed caspase 3 but not to the
zymogen forms of either caspase 3 or caspase 9.
 
Caspase 9 Processes Caspase 3 in Saccharomyces 
cerevisiae and MIHA Can Inhibit both Caspase 9 and 
Caspase 3 Processing
 
Yeast offers a convenient system in which to test mamma-
lian components of the apoptosis mechanism because yeast
do not encode caspases or their inhibitors. To test the func-
tion of MIHA in a yeast system, a truncated, constitutively
active Apaf-1 (Apaf-1
 
1–530
 
), procaspase 9, and procaspase 3
were expressed in 
 
S. cerevisiae
 
, and the effects of MIHA on
viability and caspase activation were examined. Although
autoactivating caspase 3, or caspase 3 processed by an auto-
activating caspase 9, kills 
 
S. cerevisiae
 
 (Kang et al., 1999;
Wright et al., 1999) caspase 9 alone, or caspase 9 coex-
pressed with Apaf-1
 
1–530
 
, was not toxic, even though in the
latter situation, caspase 9 processing occurred (Fig. 2, lanes
2 and 3). When wild-type caspase 3 was coexpressed with
procaspase 9 and Apaf-1, yeast growth was strongly inhib-
ited, and both caspase 9 and caspase 3 processing occurred
(Fig. 2, lane 4). In contrast, wild-type procaspase 9 did not
autoprocess or inhibit yeast growth in the absence of Apaf-1,
even when coexpressed with procaspase 3 (Fig. 2, lane 2).
These results show that activation of caspase 9 by Apaf-1
and subsequent activation of caspase 3 can be recapitulated
in 
 
S. cerevisiae
 
. Processing of caspase 9 alone was insuffi-
cient to cause death of the yeast, which required the further
activation of caspase 3 by caspase 9.
To determine where MIHA acts to prevent caspase
3–mediated yeast cell death, we coexpressed MIHA along
with the caspases and Apaf-1
 
1–530
 
 (Fig. 2, lanes 5 and 6).
MIHA was able to rescue the yeast as efficiently as the
baculoviral caspase inhibitor, p35. Processing of both
caspase 9 and caspase 3 was diminished in the presence of
MIHA. These data show that MIHA can inhibit the pro-
cessing of both caspase 3 and caspase 9. Because the pro-
cessing of caspase 3 in this system is caspase 9 dependent,
MIHA appears to inhibit active caspase 9 directly, thus
preventing it from cleaving procaspase 3. MIHA may pre-
vent cleavage of caspase 9 either directly by binding to ac-
tivated caspase 3, or indirectly by reducing the amount of
caspase 3 that becomes activated.
Figure 2. Expressing a truncated form of Apaf-1, procaspase 9
and procaspase 3 in S. cerevisiae can kill yeast, and this can be in-
hibited by MIHA. S. cerevisiae clones expressing the constructs
indicated at the top were grown under inducing (galactose) or
noninducing (glucose) conditions. Transformants expressing
truncated Apaf-1, procaspase 9, and procaspase 3 were killed
(galactose, lane 4) unless protected by either MIHA or p35 (lanes
5 and 6). The same transformants were induced in liquid medium
for 8 h, and lysates were immunoblotted with anti-caspase 9 and
anti-caspase 3 antibodies (bottom two panels). Apaf-11–530 caused
processing of caspase 9 but did not kill yeast (lane 3). Procaspase
3 was cleaved by processed caspase 9 (lane 4), which resulted in
death of the yeast. Both caspase 3 and caspase 9 processing was
inhibited by MIHA and to a lesser degree, p35. 
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MIHA Binds to Processed Caspase 9 and Functions 
Downstream of Mitochondrial Cytochrome c and 
DIABLO Release
 
To determine if MIHA could bind to caspase 9, 293T cells
were transiently transfected with MIHA and procaspase 9.
Full-length caspase 9 underwent autoprocessing under
these transfection conditions (Fig. 3, lane 2). When both
full-length and processed caspase 9 were present, MIHA
only bound to the processed, active form of caspase 9 (Fig.
3, lane 2). MIHA could not immunoprecipitate endoge-
nous procaspase 9 (Fig. 3, lane 1). When constructs encod-
ing the various subunits of caspase 9 were independently
transfected along with MIHA (Fig. 3, lanes 3–7), none
were able to bind to MIHA, including constructs encoding
the CARD and the large subunit (Fig. 3, lane 5) and the
small subunit (Fig. 3, lane 6), both of which bound to
MIHA when full-length caspase 9 was cotransfected. A
construct lacking the CARD (
 
D
 
CARD) (Hofmann et al.,
1997) also did not bind to MIHA (Fig. 3, lane 3). These re-
sults suggest that MIHA bound only to processed caspase
9 in its active configuration since MIHA bound caspase 9
only when the full-length enzyme was transfected, immu-
noprecipitating the processed subunits of the enzyme (the
p37 and p10). None of the individual subunits of caspase 9
were capable of binding to MIHA independently.
Because MIHA appears to associate preferentially with
processed caspase 9, this suggests that MIHA functions
downstream of caspase 9 cleavage. We have shown previ-
ously that MIHA does not prevent the mitochondrial re-
lease of cytochrome
 
 c
 
 or DIABLO in response to UV ra-
diation (Verhagen et al., 2000). To investigate this further,
we analyzed membrane and cytosolic fractions of UV-
treated NT2 cells stably transfected with MIHA, Bcl-2, or
LacZ (Fig. 4). In control (LacZ) cells (Fig. 4, lanes 1–6)
and MIHA-expressing cells (Fig. 4, lanes 13–18), DI-
ABLO and cytochrome
 
 c
 
 were detectable in the cytosolic
fractions 3 h after UV radiation. Caspase 9 and caspase 3
were present almost exclusively in the cytosolic fractions
and were processed in control cells after UV radiation. In
cells expressing Bcl-2 (Fig. 4, lanes 7–12) or MIHA, pro-
cessing of caspase 9 and caspase 3 in response to UV radi-
ation was prevented. These data suggest that MIHA func-
tions downstream of cytochrome
 
 c
 
 and DIABLO release
from mitochondria to prevent full activation of caspase 9,
whereas Bcl-2 acts upstream of the mitochondrial events.
Together with the results showing the effect of MIHA on
caspase cleavage in response to UV radiation, this suggests
that in mammalian cells, as in the yeast system, MIHA
functions primarily to prevent the activation of caspase 3
by active caspase 9 and can also prevent the feedback
cleavage of caspase 9.
 
DIABLO Disrupts MIHA Binding to Processed 
Caspase 9
 
DIABLO can antagonize the antiapoptotic functions of
MIHA (Du et al., 2000; Verhagen et al., 2000). To deter-
mine how it does so, 293T cells were transfected with
caspase 9 and varying ratios of DIABLO and MIHA (Fig.
5). MIHA coimmunoprecipitated processed caspase 9 in
the absence of transfected DIABLO or when the MIHA/
DIABLO ratio was 4:1 (lanes 1–2). At ratios less than
Figure 3. MIHA binds to processed, active caspase 9 and not to
the zymogen form of caspase 9. 293T cells were transfected with
Flag-tagged MIHA and the indicated constructs (EV, empty vec-
tor;  DCARD, caspase 9 lacking the prodomain; CARD, pro-
domain only; p37, prodomain and large subunit; p10, small
subunit only; p19, large subunit only). MIHA was immunoprecip-
itated and the lysates and immunoprecipitate (IP) were probed
with the antibodies indicated on the left. Two caspase 9 antibod-
ies were used: A, which recognizes the p10 and DCARD as well as
full-length caspase 9 and the p37; and B, which recognizes the
CARD and the p19 as well as the p37 fragment of caspase 9 and
full-length caspase 9. FL, anti-Flag antibody. MIHA coimmuno-
precipitated the processed (37-kD) and p10 subunit of caspase 9
(lane 2) but only when caspase 9 was transfected as a full-length
construct and underwent processing within the cell (lane 2). None
of the individual components of caspase 9 immunoprecipitated
with MIHA, suggesting that MIHA binds only to the processed
enzyme in its active conformation. 
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this, DIABLO was able to prevent the binding of MIHA
to processed caspase 9, even though similar amounts of
caspase 9 and MIHA were present (lanes 3–5). These
data show that DIABLO counters the antiapoptotic ac-
tion of MIHA by preventing MIHA from associating with
active caspase 9.
 
Discussion
 
The antiapoptotic activity of a subgroup of mammalian
IAPs (MIHA/XIAP, MIHB/cIAP1, and MIHC/cIAP2)
has been ascribed principally to the ability of these pro-
teins to directly inhibit both active caspases and caspase
activation. XIAP, cIAP1, and cIAP2 have been shown to
bind to activated caspase 3 and procaspase 9 (Deveraux et
al., 1997, 1998; Takahashi et al., 1998). We have shown
that MIHA, the murine homologue of XIAP (Uren et al.,
1996), is able to inhibit caspase 9 and caspase 3 activation
in response to UV radiation and that MIHA can associate
with endogenous, processed caspases 3 and transfected
caspase 9. We were not able to demonstrate any binding of
MIHA with procaspase 3 or procaspase 9, either in re-
sponse to a death stimulus (serum withdrawal or UV radi-
ation) or in a transient transfection assay.
The binding of MIHA to processed caspase 3 did not
appear to be sufficient for MIHA to inhibit apoptosis.
We observed association between MIHA and processed
caspase 3 under conditions in which caspase 3 became acti-
vated, including serum withdrawal where caspase 3 activa-
tion appeared independent of caspase 9 activation and
when the cells were ultimately to die. However, when ap-
optosis was induced by UV radiation, a death stimulus in
which caspase 9 was processed and in which caspase 9 has
been shown to play a critical role (Hakem et al., 1998),
MIHA was able to inhibit apoptosis. These results suggest
that while MIHA can bind to and inhibit both processed
caspase 3 and caspase 9, the interaction with caspase 9 is
more critical for the inhibition of apoptosis.
The prodomain of caspase 9 contains a CARD that me-
diates binding between caspase 9 and Apaf-1 (Day et al.,
1999; Qin et al., 1999). MIHA was able to bind to the pro-
cessed, active form of caspase 9 (containing the CARD)
but not to the individual subunits of caspase 9 when trans-
fected independently. MIHA coimmunoprecipitated with
the CARD and large subunit (p37) and the small subunit
(p10) when these were generated by autoprocessing of the
proenzyme. This strongly suggests that MIHA binds to the
processed, active heterotetrameric form of caspase 9
rather than the zymogen form of the enzyme as has been
Figure 4. MIHA acts down-
stream of mitochondrial cyto-
chrome  c  and DIABLO release.
NT2 cells stably transfected with
LacZ, Bcl-2, or MIHA were ex-
posed to UV radiation for the
indicated times. The cells were
harvested and membrane and
cytosolic fractions were sepa-
rated. The two fractions were
then immunoblotted with anti-
caspase 3, anti-caspase 9,
anti-cytochrome c  and anti-
DIABLO antibodies. Control
(LacZ) cells show translocation
of cytochrome c and DIABLO
to the cytosolic fraction and
cleavage of cytosolic caspase 3 and caspase 9 (lanes 1–6). All these processes were inhibited in cells expressing Bcl-2 (lanes 7–12).
MIHA inhibited processing of caspase 9 and caspase 3, but cytochrome c and DIABLO translocated from membrane to cytosolic frac-
tions to the same degree as in control cells (lanes 13–18).
Figure 5. DIABLO inhibits the binding of processed caspase 9 to
MIHA. 293T cells were transfected as indicated. 48 h after trans-
fection, the lysates were harvested and MIHA was immunoprecip-
itated. Both the lysates and the immunoprecipitates (IP, indicated
on the left) were immunoblotted with anti-caspase 9, anti-
DIABLO, and anti-Flag antibody. MIHA coimmunoprecipitated
processed, but not full-length, caspase 9 (lane 1). This association
persisted when the MIHA/DIABLO ratio was 4:1 (lane 2) but was
significantly inhibited by DIABLO at lower ratios (lanes 3–6). En-
dogenous and transfected DIABLO were able to associate with
MIHA. The full-length (50-kD) and processed forms (37-kD) of
caspase 9 were present in the lysates. Transfected DIABLO was
expressed in both an unprocessed (25-kD) and processed (23-kD)
form. The processed form coimmunoprecipitated with MIHA. 
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reported previously (Deveraux et al., 1998). One possible
reason for this discrepancy with previously published re-
sults is that in our system, both inactive and active caspase
9 are available for binding, allowing MIHA to demon-
strate a preference for binding to the active form of the en-
zyme. In other systems, only the zymogen form of the en-
zyme was available for binding. Another explanation is
that MIHA is able to bind initially to the zymogen form of
caspase 9, but is unable to prevent subsequent caspase 9
processing within the apoptosome. Our data do not define
the interacting domains of caspase 9 or MIHA. Thus,
MIHA may act like the 
 
Drosophila
 
 IAP, DIAP1, which
can bind to the caspase DRONC via its CARD (Meier et
al., 2000), although other evidence suggests that XIAP can
bind to caspase 9 (lacking a CARD) via its BIR3 (Sun et
al., 2000).
In mammalian cells and in yeast, our data show that
caspase 9 processes caspase 3 and this can be inhibited by
MIHA. The partial inhibition of caspase 9 processing by
MIHA suggests either that MIHA can inhibit autocata-
lytic activation of caspase 9, or that it can inhibit process-
ing of caspase 9 by caspase 3 in an amplification loop. Such
an amplification loop is consistent with the ability of
MIHA to bind to endogenous processed caspase 3 and the
ability of caspase 3 to cleave and activate caspase 9 (De-
veraux et al., 1998; Woo et al., 1999). Furthermore, experi-
ments in caspase 9–deficient mice show that in some death
pathways, caspase 3 cleavage is caspase 9 dependent
(Hakem et al., 1998; Kuida et al., 1998). MIHA functions
by binding to the active forms of these caspases and pre-
venting the amplification loop from proceeding. This ex-
plains the apparent paradox that although MIHA binds to
processed caspases, it is nevertheless able to reduce the
amount of caspase cleavage.
Once released from mitochondria, DIABLO functions
to prevent MIHA from binding to processed caspase 9 and
thereby stops MIHA from blocking the amplification of
caspase activation. Whereas high levels of DIABLO can
efficiently neutralize MIHA, DIABLO cannot antagonize
the antiapoptotic effect of Bcl-2, not only because Bcl-2
prevents DIABLO release from mitochondria, but also
because it can block signals that lead to caspase 9 activa-
tion (Verhagen et al., 2000).
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